• Contact us
  • Email Whitelisting
  • Home 1
  • Privacy Policy
  • Terms & Conditions
  • Thank you
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
  • Health Care
  • Health News
  • Healthy Advices
  • Well Being
No Result
View All Result
Wholesome Area - Beauty Secrets and Tips
No Result
View All Result
Home Health Care

Target recalls kids’ weighted blankets after two girls die of asphyxiation

by
December 23, 2022
in Health Care
0
Target recalls kids’ weighted blankets after two girls die of asphyxiation
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

Target recalled more than 200,000 children’s weighted blankets on Thursday after two girls were reportedly entrapped inside one and died of asphyxiation in the spring.

The U.S. Consumer Product Safety Commission (CPSC) and the big box chain announced the recall of 204,000 Pillowfort Weighted Blankets, citing a safety risk if a child unzips and enters the blanket.

In April, a 4-year-old girl and a 6-year-old girl were trapped inside the cover of a weighted blanket and died of asphyxiation at Camp Lejeune, N.C., the agency said.

Target has received four reports of children becoming entrapped in the product, including that instance.

Both CPSC and Target are urging consumers to stop using the weighted blankets and return the products immediately.

Pillowfort Weighted Blankets weigh six pounds and are 60 inches long and 40 inches wide.

Weighted blankets are commonly used therapeutically to assist with sleep and reduce anxiety.

Previous Post

COVID, drug overdoses drive life expectancy drop

Next Post

FDA updates Plan B product labelling, clarifies it is not an abortion pill

Next Post
FDA updates Plan B product labelling, clarifies it is not an abortion pill

FDA updates Plan B product labelling, clarifies it is not an abortion pill

  • Trending
  • Comments
  • Latest
Americans die younger in states with conservative policies: study

Americans die younger in states with conservative policies: study

October 27, 2022
Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

Those at risk for severe COVID-19 often least likely to get monoclonal antibodies

April 26, 2022
Biden says US has offered vaccines to North Korea but got no response

Biden says US has offered vaccines to North Korea but got no response

May 21, 2022
Medicaid cuts could define midterms

Medicaid cuts could define midterms

July 7, 2025
Oz: Millions may be falsely enrolled in ObamaCare

Oz: Millions may be falsely enrolled in ObamaCare

0
Health Care — Draft Supreme Court opinion sets off uproar

Health Care — Draft Supreme Court opinion sets off uproar

0
UN calls reproductive rights ‘foundation’ of equality for women and girls

UN calls reproductive rights ‘foundation’ of equality for women and girls

0
57 percent in new poll want Supreme Court to support abortion rights

57 percent in new poll want Supreme Court to support abortion rights

0
Oz: Millions may be falsely enrolled in ObamaCare

Oz: Millions may be falsely enrolled in ObamaCare

March 10, 2026
RFK Jr. undergoing rotator cuff surgery

RFK Jr. undergoing rotator cuff surgery

March 10, 2026
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

March 10, 2026
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

March 9, 2026

Recent News

Oz: Millions may be falsely enrolled in ObamaCare

Oz: Millions may be falsely enrolled in ObamaCare

March 10, 2026
RFK Jr. undergoing rotator cuff surgery

RFK Jr. undergoing rotator cuff surgery

March 10, 2026
FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

March 10, 2026
Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

Hims & Hers to partner with Novo Nordisk and stop selling compounded GLP-1s

March 9, 2026
Enter Your Information Below To Receive Free Health and Beauty Tips and Ideas





    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2026 wholesomearea.com | All Rights Reserved

    No Result
    View All Result
    • Health Care
    • Health News
    • Healthy Advices
    • Well Being

    Copyright © 2026 wholesomearea.com | All Rights Reserved